Summary
We evaluated the electrophysiological mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline in seven patients, pilsicainide in two, and disopyramide in two, and procainamide in three) in the induction of orthodromic atrioventricular re-entrant tachycardia (AVRT). In 14 patients (10 males, 4 females; mean age 37±18 years) who had inducible AVRT despite the administration of class I drugs, electrophysiological effects of class I antiarrhythmic drugs were evaluated using programmed electrical stimulation techniques. In 4 out of 6 patients with a manifest accessory pathway, class I drugs induced unidirectional conduction block of the accessory pathway (antegrade conduction block associated with preserved retrograde conduction) and enhanced the induction of AVRT with atrial extrastimulation. In eight patients with a concealed accessory pathway, the outward or inward expansion of the tachycardia induction zone was observed in patients who had greater prolongation of the conduction time than the refractory period of the retrograde accessory pathway after class I drugs. During ventricular extrastimulation, the induction of bundle branch reentry after class I drugs initiated the AVRT in patients with either manifest or concealed accessory pathways. We conclude that the adverse effects of class I drugs are mainly due to induction of unidirectional retrograde conduction of the manifest accessory pathway and the greater prolongation of the retrograde conduction time of the concealed accessory pathway than the refractory period, regardless of the subclassification of class I drugs.
Similar content being viewed by others
References
Kang PS, Gomes JAC, El-Sherif N, Procainamide in the induction and perpetuation of ventricular tachycardia in man.PACE 1982;5:311–322.
Au PK, Bhandari AK, Bream R, Schreck D, Siddiqi R, Rahimtoola SH. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.J Am Coll Cardiol 1987;9:389–397.
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary Report. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.N Engl J Med 1989; 321:406–410.
Neuss H, Buss J, Schlepper M, et al. Effects of flecainide on electrophysiological properties of accessory pathways in the Wolff-Parkinson-White syndrome.Eur Heart J 1983;4: 347–353.
Kerr CR, Prystowsky EN, Smith WM, Cook L, Gallagher JJ. Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome.Circulation 1982;65:869–878.
Eldar M, Ruder MA, Dovis JC, et al. Procainamide-induced incessant supraventricular tachycardia in the Wolff-Parkinson-White syndrome.PACE 1986;9:652–659.
Fujiki A, Mizumaki K, Tani M, Yoshida S, Sasayama S. Electrophysiologic effects and efficacy of cibenzoline in patients with supraventricular tachycardia.J Cardiovasc Pharmacol 1992;20:375–379.
Cockrell JL, Scheinman MM, Titus C, et al. Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia.Ann Intern Med 1991;114: 189–194.
Klein GJ, Bashore TM, Sellers TD, Pritchett ELC, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome.N Engl J Med 1979;301: 1080–1085.
Akhtar M, Lehmann MH, Denker ST, Mahmud R, Tchou P, Jazayeri M. Electrophysiologic mechanisms of orthodromic tachycardia initiation during ventricular pacing in the Wolff-Parkinson-White syndrome.J Am Coll Cardiol 1987; 9:89–100.
Kuck KH, Schluter M, Geiger M, Siebels J, Duckeck W. Radiofrequency current eatheter ablation of accessory atrioventricular pathways.Lancet 1991;337:1557–1561.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fujiki, A., Tani, M., Yoshida, S. et al. Electrophysiologic mechanisms of adverse effects of class I antiarrhythmic drugs (cibenzoline, pilsicainide, disopyramide, procainamide) in induction of atrioventricular re-entrant tachycardia. Cardiovasc Drug Ther 10, 159–166 (1996). https://doi.org/10.1007/BF00823594
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00823594